PLA/MSM缓释微球的制备及生物活性

采用膜乳化-液中干燥法制备出担载二甲基砜(MSM)的聚乳酸(PLA)微球(PLA/MSM), 并研究了膜孔径、 搅拌转速和MSM浓度对载药微球形貌、 尺寸、 载药量、 体外释放及细胞活性的影响; 采用场发射环境扫描电子显微镜(ESEM)观察微球形貌、 尺寸及分布, 用等离子体发射光谱(ICP-AES)法检测PLA/MSM微球载药量、 包封率及体外释放, 采用ESEM观察微球内部结构, 并通过体外细胞培养和噻唑蓝(MTT)法检测MC-3T3-E1细胞的增殖能力. 研究结果表明, 膜乳化法制备的载药微球规整, 呈典型的圆球状, 表面光滑, 内部有多孔结构. 当膜孔径为5.1 μm且搅拌转速为500 r/min时, PLA/MSM微球大小更为均一; 当体系中MSM质量分数为8.6%时, 载药量可达到77.43%. 随着膜孔径减小及药物浓度的增加, 体外释放速率加快, 但初期均无明显的突释现象, 约10 d后累积释放量达到89.2%. 细胞实验结果显示, 在膜孔径为5.1 μm且MSM质量分数为8.6%的条件下, 制备的载药微球在细胞培养7 d时表现出明显的促增殖作用.     

Effect of method of preparation and process variables on controlled release of insoluble drug from chitosan microspheres

An inexpensive and simple method was adopted for the preparation of chitosan microspheres, crosslinked with glutaraldehyde (GA), for the controlled release of an insoluble drug‐ibuprofen, which is a commonly used NSAID (non‐steroidal anti‐inflammatory drug). The chitosan microspheres were prepared by different methods and varying the process conditions such as rate of stirring, concentration of crosslinking agent, and drug:polymer ratio in order to optimize these process variables on microsphere size, size distribution, degree of swelling, drug entrapment efficiency, and release rates. The absence of any chemical interaction between drug, polymer, and the crosslinking agent was confirmed by Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), and thermogravimetric analyses (TGA) techniques. The microspheres were characterized by optical microscopy, which indicated that the particles were in the size range of 30–200 µm and scanning electron microscopy (SEM) studies revealed a smooth surface and spherical shape of microspheres. The microsphere size/size distributions were increased with the decreased stirring rates as well as GA concentration in the suspension medium. Decreasing the concentration of crosslinker increased the swelling ratio whereas extended crosslinking exhibited lowered entrapment efficiency. The in vitro drug release was controlled and extended up to 10 hr. Copyright © 2007 John Wiley & Sons, Ltd.     

Aripiprazole Loaded Polymeric Biodegradable Microspheres: Formulation and In Vitro Characterization

In the present study, we attempted to prepare biodegradable microspheres of polylactic acid containing aripiprazole in order to achieve its controlled release profile suitable for parenteral administration. Biodegradable microspheres were prepared by solvent evaporation method using methylene dichloride as a solvent. The optimization of various formulation variables (e.g., stirring speed, and polymer:drug ratio, stabilizer concentration) to obtain spherical particles was also investigated. The optimized product was further characterized for various in vitro attributes, such as particle size and its distribution, encapsulation efficiency, surface properties, percentage yield, and in vitro release. Changing the ratio of polymer, stabilizers, and leaching agent (sodium chloride) affected the entrapment efficiency and release rate of aripiprazole. The release quantum was 88.41% when stirring rate was 2000 rpm and it was further increased to 94.65% when stirring speed was increased to 3000 rpm (Formulation E). Drug entrapment of microspheres was increased by increasing the concentration of PVP and maximum entrapment (62.35%) was obtained at 4% concentration of PVP (Formulation E). Spherical particles with good surface characteristics were obtained at stirring rate 3000 rpm and drug:polymer ratio 1:10.     

The influence of chitosan on in vitro properties of Eudragit RS microspheres

Eudragit RS microspheres containing chitosan hydrochloride were prepared by the solvent evaporation method using acetone/liquid paraffin solvent system and their properties were compared with Eudragit RS microspheres without chitosan, prepared in our previous study. Different stirring rates were applied (400-1200 rpm) and drug content, Higuchi dissolution rate constant, surface and structure characteristics of the microspheres were determined for each size fraction. An increase in average particle size with a reduction of stirring rate appeared in limited interval in both series. The average particle size of microspheres without chitosan, prepared at the same stirring rate, was smaller. Pipemidic acid content increased with increasing fraction particle size, but not with increasing stirring rate as it was observed for microspheres without chitosan. We presume that high pipemidic acid content in larger microspheres is a consequence of cumulation of undissolved pipemidic acid particles in larger droplets during microspheres preparation procedure. Pipemidic acid release was faster from microspheres with chitosan and no correlation between Higuchi dissolution rate constant and stirring rate or fraction particle size was found, though it existed in the system without chitosan. Structure and surface characteristics of microspheres observed by scanning electron microscope (SEM) were not changed significantly by incorporation of chitosan. But in contrast with microspheres without chitosan, the surface of chitosan microspheres was more porous after three hours of dissolution. It is supposed that the influence of particle size fraction and stirring rate on release characteristics is expressed to a great extent through porosity and indirectly through total effective surface area, but the incorporation of highly soluble component i.e. chitosan salt hides these effects on drug release. In conclusion, changes in biopharmaceutical properties due to varying stirring rate and fraction particle size exhibited the same direction as those reported for the microspheres without chitosan, although they are less expressed because of increased experimental variability, likely caused by chitosan.     

粒径和孔径可控的多孔交联聚苯乙烯微球的制备

采用悬浮聚合方法合成了多孔交联聚苯乙烯微球,研究发现微球的粒径与分散剂含量、水油比、搅拌速度和成孔剂有关,而微球的孔径与成孔剂的种类和含量有关。 增加分散剂的用量,提高水油比和加快搅拌速度都能导致微球的粒径减小。 微球的孔径和粒径均随着成孔剂与聚合物溶度参数差值变大而增加。通过改变以上条件得到粒径为100~300 μm和孔径为8~36 nm的交联度为27%的多孔交联聚苯乙烯微球,并利用光学显微镜、场发射扫描电子显微镜(SEM)和氮气吸附解吸法对微球进行了相应的表征。 得到的微球在固相合成载体中有一定的应用前景。     

不同溶剂制备的聚乳酸多孔微球的形成机理

利用改进的双乳液溶剂挥发法制备了多孔聚乳酸( PLA)微球.通过采用具有不同沸点和水溶性的有机溶剂制备得到不同多孔结构的PLA微球.结果发现以二氯甲烷、氯仿和甲苯为溶剂制备的微球具有相似的均匀多孔结构,而以乙酸乙酯制备的微球却具有中空结构和多孔的壳层.通过进一步的实验研究了溶剂种类对于微球多孔结构的影响.结果表明溶剂的...     

Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification

Amphiphilic co-polymer, which can maintain the stability of proteins and increase the protein loading efficiency, is considered as an exploring-worthy biodegrade polymer for drug delivery. However, amphiphilic microcapsules prepared by conventional methods, such like mechanical stirring and spray-drying methods, exhibit broad size distributions due to its hydrophilic sequences, leading to poor reproducibility. In this study, we employed poly(monomethoxypoly ethylene glycol-co-D,L-lactide) (mPEG-PLA, PELA), one of common amphiphilic polymers, as model to focus on investigating the process parameters and mechanisms to prepare PELA microcapsules with narrow size distribution and regular sphericity by combining premix membrane emulsification and double emulsion technique. The coarse double emulsion with broad size distribution was repeatedly pressed through Shirasu Porous Glass (SPG) membrane with relatively high pressure to form the fine emulsion with narrow size distribution. Then, the microcapsules with narrow size distribution can be obtained by solvent extraction method. It was found that it was more difficult to obtain PELA microcapsules with narrow size distribution and smooth surface due to its amphiphilic property, compared with the cases of PLA and PLGA. The smooth surface morphology was found to be related to several factors including internal water phase with less volume, slower stirring rate during solidification and using ethyl acetate as oil phase. It was also found that mass ratio of hydrophilic mPEG, stabilizer PVA concentration in external water phase and transmembrane pressure played important role on the distribution of microcapsules size. The suitable preparation conditions were determined as follows: for the membrane with pore size of 2.8 μm, the mass ratio of PLA/mPEG was 19:1, volume ratio of W(1)/O was 1:10 and O/W(2) was 1:5, PVA concentration (w/v) was 1.0%, magnetic stirring rate during solidification was 60 rpm and 300 kPa was chosen as transmembrane pressure. There was a linear relationship between the diameter of microcapsules and the pore size of the membranes. Finally, by manipulating the process parameters, PELA microcapsules with narrow size distributions (coefficient of variation was less than 15%), smooth morphology and various sizes, were obtained. Most importantly, the key factors affecting fabrication have been revealed and mechanisms were illustrated in detail, which would shed light on the research of amphiphilic polymer formulation.     

生物可降解5-氟尿嘧啶载药微球的制备及性能研究

5-氟尿嘧啶(5-Fu)为水溶性嘧啶类抗代谢药,是治疗实体肿瘤的首选药物．但5-Fu毒性很大,血浆中停留半衰期t1／2仅为10～20min．为了减少氟尿嘧啶的毒副作用并提高药物利用率,可以将其制成聚合物载药微球．聚酯类高分子是较为常用的生物降解型药物载体材料,其中聚乳酸(PLA)及其共聚物具有良好的生物相容性及生物可降解性,常被广泛应用于药物缓释材料,     

Preparation of PLGA microspheres with different porous morphologies

Poly(D,L-lactide-co-glycolide)(PLGA) microspheres were prepared by emulsion solvent evaporation method. The influences of inner aqueous phase, organic solvent, PLGA concentration on the morphology of microspheres were studied. The results showed that addition of porogen or surfactants to the inner aqueous phase, types of organic solvents and polymer concentration affected greatly the microsphere morphology. When dichloromethane was adopted as organic solvent, microspheres with porous structure were produced. When ethyl acetate served as organic solvent, two different morphologies were obtained. One was hollow microspheres with thin porous shell under a lower PLGA concentration, another was erythrocyte-like microspheres under a higher PLGA concentration. Three types of microspheres including porous, hollow core with thin porous shell(denoted by hollow in brief) and solid structures were finally selected for in vitro drug release tests. Bovine serum albumin(BSA) was chosen as model drug and encapsulated within the microspheres. The BSA encapsulation efficiency of porous, hollow and solid microspheres was respectively 90.4%, 79.8% and 0. And the ultimate accumulative release was respectively 74.5%, 58.9% and 0. The release rate of porous microspheres was much slower than that of hollow microspheres. The experiment results indicated that microspheres with different porous structures showed great potentials in controlling drug release behavior.     

Preparation of Monodispersed Polymer Microspheres by SPG Membrane Emulsification‐Solvent Evaporation Technology

The membrane emulsification coupled with solvent evaporation was adopted to prepare monodispersed polystyrene (PS) microspheres. Firstly, stable oil‐in‐water emulsion has been successfully obtained by pressing PS solution through SPG membrane into continuous phase at appropriate pressures. Then monodispersed PS microspheres with size of 2–20 µm were obtained following the removal of solvent. The size of the PS microspheres was strongly dependent on the mean pore size of SPG membrane and concentration of PS solution. Furthermore, the effect of emulsion stability, operation pressure and emulsifier on the size and size distribution of microspheres were systemically investigated. Finally, the surface character of PS microspheres was examined via SEM.     

Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres

Poly(lactide-co-glycolide), PLGA, microspheres containing blue dextran as a hydrophilic model drug were prepared by a solvent evaporation method from w/o/w emulsions using a micro homogenizer. Effects of surfactant concentration in oil phase, stirring time period and stirring rate in the preparation procedure of primary emulsion (w/o) upon drug-loading efficiency were evaluated. Stirring rate during preparation of primary emulsion and surfactant concentration in oil phase affected drug-loading efficiency and the particle size of primary emulsion. Microspheres having the higher drug-loading efficiency were obtained when size differences between the primary emulsions and the secondary ones were large. That is, when the diameter of the primary emulsion is much smaller than that of the secondary emulsion, PLGA microspheres with high-loading efficiency of blue dextran were obtained.     

Fabrication and enhanced mechanical properties of porous PLA/PEG copolymer reinforced with bacterial cellulose nanofibers for soft tissue engineering applications

A new class of polylactic acid (PLA)/polyethylene glycol (PEG) copolymer reinforced with bacterial cellulose nanofibers (BC) was prepared using a solvent casting and particulate leaching methods. Four weight fractions of BC (1, 2.5, 5, and 10 wt%) were incorporated into copolymer via silane coupling agent. Mechanical properties were evaluated using response surface method (RSM) to optimize the impact of pore size, porosity, and BC contents. Compressive strength obtained for PLA/PEG-5 BC wt% was 9.8 MPa, which significantly dropped after developing a porous structure to 4.9 MPa. Nielson model was applied to investigate the BC stress concentration on the PLA/PEG. Likewise, krenche and Hapli-Tasi model were employed to investigate the BC nanofiber reinforcement and BC orientation into PLA/PEG chains. The optimal parameters of the experiment results found to be 5 wt% for BC, 230 μm for pore size, and 80% for porosity. Scanning electron microscopy (SEM) micrograph indicates that uniform pore size and regular pore shape were achieved after an addition of BC-5% into PLA/PEG. The weight loss of copolymer-BC with scaffolds enhanced to the double values, compared with PLA/PEG-BC % without scaffolds. Differential Scanning Calorimetric (DSC) results revealed that the BC nanofiber improved glass transition temperature (T_g) 57 °C, melting temperature (T_m) 171 °C, and crystallinity (χ %) 43% of PLA/PEG reinforced-BC-5%.     

Microporous polyethersulfone membranes prepared under the combined precipitation conditions with non‐solvent additives

Using diethylene glycol (DegOH) as non‐solvent additive (NSA) and N, N‐dimethylacetamide (DMAc) as solvent (S), polyethersulfone (PES) flat sheet membranes were prepared via immersion precipitation combined with the vapor induced phase separation (VIPS) process. Light transmittance was used to follow the precipitation rate during the immersion process as well as during the VIPS stage. As the addition of the NSA, the viscosity of casting solutions increased, which led to a slow precipitation rate. Though the precipitation rate decreased, the instantaneous demixing type was maintained. High flux membranes were obtained only at a high mass ratio of NSA/S; producing membranes had cellular pores on the top surface and sponge‐like structure on cross section. The VIPS process prior to immersion precipitation was important for the formation of cellular pore on the surface. With the increase in exposure time, the liquid–liquid phase separation took place on the surface of casting solution; nucleation and growth induced the formation of cellular pore on the top surface. Coagulation bath temperature also had large effect on the precipitation rate; high temperature on coagulation bath mainly accelerated the transfer of solvent and non‐solvent. Higher flux membrane with a porous skin layer could be obtained at a high coagulation bath temperature, but at the same time the mechanism properties were weakened. Copyright © 2007 John Wiley & Sons, Ltd.     

Preparation of biodegradable polyesteramide microspheres

Biodegradable polyesteramide copolymer P(CL/AU) based on -caprolactone and 11-aminoundecanoic acid was synthesized by the melt polycondensation method. Polyesteramide (PEA) microspheres were prepared by a simple O/W emulsion solvent evaporation method. The effects of variations in preparation parameters (such as emulsifier concentration, polymer concentration, polymer solution adding rate, stirring rate, and whether vacuum was applied) were studied in detail. The obtained microsphere morphologies were observed using an optical microscope and via scanning electron microscopy (SEM). The particle size distribution was determined using a Malvern laser particle sizer. When the PEA microspheres were incubated in PBS saline, the particle size increased at first, and then decreased after a longer time period; the theory that this behavior was due to degradation of the microspheres was confirmed by SEM.     

Simple method for preparation of porous polyimide film with an ordered surface based on in situ self-assembly of polyamic acid and silica microspheres

In this Article, we addressed a facile method for the fabrication of porous polyimide film with an ordered surface based on the solvent-evaporation-assisted in situ self-assembly of polyamic acid (PAA, precursor of polyimide) and silica microspheres during vacuum-drying of PAA/silica colloid solution. Hydroxyl groups on the surface of silica microspheres have strong hydrogen-bonding with PAA chains, which improve the dispersion of silica microspheres in PAA/DMF solution and further help the self-assembly of PAA/silica colloid solution via solvent evaporation. The approach is simple, neither the preparation of special template nor complex preparation process and precise control over condition is necessary. Furthermore, the method could be employed for mass production of ordered porous polyimide films, and by changing the content and size of silica microspheres, the pore size and porous structure of the porous polyimide films could be tunable. The wettability behavior of the as-prepared porous polyimide films is also studied; the ordered surface topography of the porous polyimide films could change the wettability from hydrophilicity to hydrophobicity.     

Encapsulation and characterization of flurbiprofen loaded poly(є-caprolactone)–poly(vinylpyrrolidone) blend micropheres by solvent evaporation method

Flurbiprofen loaded PCL/PVP blend microspheres were prepared by o/w solvent evaporation method using various concentrations of gelatin as emulsifying agent. Microsphere recovery decreased with a decrease in the concentration of the emulsifier in the dispersion. Encapsulation efficiency and drug loading of microspheres increased with decrease in concentration of emulsifying agent. Hydration rate, encapsulation efficiency and drug loading of microspheres increased with increase in concentration of PVP. Rheological properties showed free flowing nature of microspheres. SEM (Scanning electron microscope) revealed microspheres were discrete, spherical and became porous with decrease in concentration of emulsifying agent but smooth with higher concentration of emulsifying agent. FTIR (Fourier transform infrared spectroscopy) spectra of pure and encapsulated flurbiprofen in all formulation showed no significant difference in characteristic peaks, suggesting stability of flurbiprofen during encapsulation process. X-RD (X-ray powder diffractometry) of pure flurbiprofen shows sharp peaks, which decreases on encapsulation, indicating dispersion at molecular level and hence decrease in the crystallinity of drug in microspheres. Microspheres showed an enteric nature at pH 1.2 and a sustained release pattern at pH 6.8. Rapid drug release was observed in microspheres with higher concentration of PVP (polyvinylpyrrolidone), PVP acts as channeling agent. Formulation with low concentration of emulsifying agent also showed a fast release due to porous structure. Drug release kinetics followed zero order at pH 1.2 while at pH 6.8 Higuchi model was best fitted and was found non fickian.     

Non‐isothermal crystallization kinetics and spherulitic morphology of nucleated poly(lactic acid): effect of dilithium cis‐4‐cyclohexene‐1,2‐dicarboxylate as a novel and efficient nucleating agent

The effect of dilithium cis‐4‐cyclohexene‐1,2‐dicarboxylate (CHDA‐Li) as a novel and efficient nucleating agent on the crystallization behaviors and spherulitic morphology of poly(lactic acid) (PLA) as well as non‐isothermal crystallization kinetics of the nucleated PLA was studied by means of differential scanning calorimetry and polarized light microscopy. The results show that CHDA‐Li serves as a good nucleating agent to accelerate the crystallization rate of PLA. The nucleation ability of CHDA‐Li is superior to octamethylenedicarboxylic dibenzoylhydrazide. With the incorporation of CHDA‐Li, the number of the spherulites increases, and the size decreases significantly. The non‐isothermal crystallization kinetics of the nucleated PLA can be well described by Jeziorny's and Mo's models. The activation energies (ΔE) of non‐isothermal crystallization were calculated by Kissinger's and Friedman's methods. The crystallization rate of PLA/0.5 wt% CHDA‐Li sample is faster than that of PLA/0.2 wt% CHDA‐Li sample, while the ΔE of the former is lower than that of the latter. Copyright © 2015 John Wiley & Sons, Ltd.     

W/O乳化法制备明胶/β-磷酸三钙多孔复合微球及其热学性能

采用乳液、离子缔合法制备得到明胶(Gel)/β-纳米磷酸三钙(β-TCP)复合多孔微球,其尺寸可通过控制反应的搅拌速度进行调节. SEM和光学显微镜观察表明,明胶/β-TCP复合微球尺寸在20～40 μm之间,被包敷的磷酸三钙为200 nm左右,微球内部呈多孔结构. 当m(磷酸三钙)∶m(明胶)＞0.4∶1时,有大量花瓣状晶体附着于复合微球的表面,是磷酸三钙溶解和明胶分子诱导重结晶所致. XRD与IR图谱表明,磷酸三钙纳米粒子与明胶之间存在化学键合,明胶/β-纳米磷酸三钙复合微球的微观结构与自然骨相似. DSC-TGA结果显示,90%的TCP在乳化过程中与明胶复合. 本文所制备的复合微球,为添加各种药物和促骨生长因子并实现缓释提供了优良的载体.     

Polymer Structure‐Guided Self‐Assisted Preparation of Poly(ester‐thioether)‐Based Hollow Porous Microspheres and Hierarchically Interconnected Microcages for Drug Release

Porous polymer microspheres (PPMs) have been widely applied in various biomedical fields. Herein, the self‐assisted preparation of poly(ester‐thioether)‐based porous microspheres and hierarchical microcages, whose pore sizes can be controlled by varying the polymer structures, is reported. Poly(ester‐thioether)s with alkyl side chains (carbon atom numbers were 2, 4, and 8) can generate hollow porous microspheres; the longer alkyl chain length, the larger pore size of microspheres. The allyl‐modified poly(ester‐thioether) (PHBDT‐g‐C₃) can form highly open, hierarchically interconnected microcages. A formation mechanism of these PPMs is proposed; the hydrophobic side chains‐mediated stabilization of oil droplets dictate the droplet aggregation and following solvent evaporation, which is the key to the formation of PPMs. The hierarchically interconnected microcages of PHBDT‐g‐C₃ are due to the partially crosslinking of polymers. Pore sizes of PPMs can be further tuned by a simple mixing strategy of poly(ester‐thioether)s with different pore‐forming abilities. The potential application of these PPMs as H₂O₂‐responsive vehicles for delivery of hydrophobic (Nile Red) and hydrophilic (doxorubicin hydrochloride) cargos is also investigated. The microspheres with larger pore sizes show faster in vitro drug release. The poly(ester‐thioether)‐based polymer microspheres can open a new avenue for the design of PPMs and provide a H₂O₂‐responsive drug delivery platform.     

口服聚酯聚醚疫苗蛋白微球的制备研究

采用本体聚合法合成不同聚醚含量的聚酯聚醚嵌段共聚物聚 ＤＬ 乳酸 聚乙二醇（Ｐｏｌｙ ＤＬ ｌａｃｔｉｄｅ ｂ ｐｏｌｙｅｔｈｙｌｅｎｅｇｌｙｃｏｌ,ＰＥＬＡ）．ＰＥＬＡ及ＰＬＡ包裹人血清白蛋白（ＨＳＡ）微球采用溶剂挥发法双乳液体系（Ｗ１／Ｏ／Ｗ２）制备．微球球形规整,粒径集中在０５～５０μｍ．用ＣＢＢ法检测微球中蛋白含量,蛋白包裹量达２５％,包裹效率近８０％．从双乳液体系中界面张力角度考察了聚合物囊材的性质、稳定剂的种类及Ｗ１／Ｏ的稳定性等对微球粒径及蛋白包裹量的影响．微球体外释放结果表明ＰＥＬＡ蛋白微球的突释现象不明显,释放速度较为恒定．